The abnormal activation of DNM1L has been reported in Alzheimer’s disease (Cho et al., 2009) and Huntington’s disease (Shirendeb et al., 2011; Song et al., 2011), both of which promoted mitochondrial fission and damaged neurons. Here, DNM1L is linked to juvenile Huntington disease.